Bangkok, Thailand – 14 February 2025– Healwell Pharmaceuticals Sdn Bhd has been honored with a prestigious award for its Golden Sea Cucumber Polypeptide at the Bangkok International Intellectual Property, Invention, Innovation, and Technology Exposition (IPITEx) 2025. The company received a Gold Medal in the Class A category (Medicine and Public Health), along with the Outstanding Invention & Innovation Award from the National Research Council of Thailand (NRCT), a government organization under the Ministry of Higher Education, Science, Research, and Innovation. This achievement highlights Healwell’s groundbreaking innovation and contributions to medical research, particularly in the treatment of wound healing and diabetic gangrene.
The award-winning Golden Sea Cucumber Polypeptide was recognized for its effectiveness in treating various wounds, diabetic gangrene, and skin conditions such as dermatitis and psoriasis. This invention has the potential to accelerate wound healing treatments and simplify procedures in both hospitals and home settings. Additionally, it offers a promising solution for severe and life-threatening cases of diabetic gangrene, increasing survival rates among patients. Its cost-effectiveness could also help reduce rising healthcare costs, benefiting both individuals and governments.
The award recipients include Professor Dato’ Dr Hassan Yaakob, the founder and Executive Chairman of Healwell Pharmaceuticals, along with his research team: Professor Dr Kim Kah Hwi, Dr Kim Wee Ric, and Dr Goh Nge Seung. Also recognized was the company’s Chief Operating Officer, Mr. Mukhzani Hassan.
The event, attended by industry experts, investors, and innovators from over 30 countries, served as a platform for showcasing groundbreaking ideas and fostering collaborations. Healin’s success at IPITEx 2025 underscores its dedication to pushing the boundaries of medical innovation and technology.
In addition to this achievement, Healwell Pharmaceuticals has received several other prestigious awards, including the International Innovation Award from the Association of British Inventors and Innovators, as well as two special awards from the Thai Biomedical Engineering Association and the Filipino Inventors Society.
Healwell Pharmaceuticals is a Malaysian pharmaceutical company founded by Professor Dato’ Dr Hassan Yaakob, a medical doctor and pharmacology researcher. The company specializes in formulating health products based on its own innovations using natural resources such as sea cucumber and chlorophyll. Healwell’s products, including Gamogen, Zaniplus, Lukano, and Derma X, are available at Healin outlets, pharmacies, and online platforms in Malaysia.
With this latest recognition, Healwell Pharmaceuticals looks forward to local and international partnerships for further clinical research on the potential treatments using Golden Sea Cucumber Polypeptide. The company also aims to expand Healin’s product line and collaborate with clients interested in private-label manufacturing. This achievement not only marks a personal milestone for Healwell but also contributes to the advancement of traditional and natural medicine on a global scale.
For more information about Healwell Pharmaceuticals and its invention, please contact mukhzani@healin.my.
This version improves readability, corrects grammar, and enhances professionalism while keeping the message intact. Let me know if you’d like any further refinements!